GSK Investigational Site

Rio Piedras, Puerto Rico 00935

0 studies enrolling now · 1 studies all time

What they study most

Infection, Human Immunodeficiency Virus

Studies at this site

• A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen — Completed